Monmouth Junction, NJ, United States of America

Xiaowei Xu

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Monmouth Junction, NJ (US) (2015 - 2020)
  • Monmouth Drive, NJ (US) (2021)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Xiaowei Xu

Introduction

Xiaowei Xu is a prominent inventor based in Monmouth Junction, NJ (US), known for his significant contributions to the field of cancer research and treatment. With a total of five patents to his name, Xu has made strides in developing innovative solutions for diagnosing and treating cancer.

Latest Patents

Xu's latest patents include groundbreaking work on extracellular vesicle proteins, which are utilized for cancer diagnosis and predicting patient responses to therapy. His compositions and methods aim to treat cancer patients and identify those likely to respond to anti-PD-1/PD-L1 therapies and other immune-modulating treatments. Additionally, he has developed resiquimod topical and injectable compositions for treating neoplastic skin conditions. These compositions address viral skin diseases, as well as precancerous and cancerous skin conditions.

Career Highlights

Throughout his career, Xu has worked with esteemed institutions such as the University of Pennsylvania and The Wistar Institute of Anatomy & Biology. His work has been instrumental in advancing the understanding and treatment of various malignancies.

Collaborations

Xu has collaborated with notable colleagues, including Ruifeng Yang and Shujing Liu, contributing to a rich exchange of ideas and innovations in the field.

Conclusion

Xiaowei Xu's innovative work in cancer research and treatment exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for advancements in cancer diagnosis and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…